Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy

Journal of Medical Genetics

Volumn 44, Issue 6, 2007, Pages 368-372

  Taylor, Peter J ^a   Maroulis, Sarah ^a   Mullan, Glenda L ^a   Pedersen, Robyn L ^b   Baumli, Aurora ^a   Elakis, George ^a   Piras, Sara ^a   Walsh, Corrina ^a   Prósper Gutiérrez, Benito ^a   De La Puente Alonso, Fernando ^a   Bell, Christopher G ^a   Mowat, David R ^b   Johnston, Heather M ^b   Buckley, Michael F ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DYSTROPHIN;

ANALYTIC METHOD; ARTICLE; BECKER MUSCULAR DYSTROPHY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DNA SEQUENCE; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE DELETION; GENE DUPLICATION; GENE MUTATION; HETEROZYGOTE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

FEMALE; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; MALE; MOTHERS; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION;

EID: 34250721622     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2006.047464     Document Type: Article

References (29)

1. Bushby K, Bourke J, Bullock R, Eagle M, Gibson M, Quinby J. The multidisciplinary management of Duchenne muscular dystrophy. Curr Paediatr 2005;15:292-300.
2. Chamberlain JS, Gibbs RA, Ranier JE, Caskey CT. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy. In: Innis MA, Gelfand DH, Sninsky JJ, et al, eds. PCR protocols: a guide to methods and applications. San Francisco (USA): Academic Press, 1990:272-81.
3. Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990;86:45-8.
4. Bakker E, Bonten EJ, De Lange LF, Veenema H, Majoor-Krakauer D, Hofker MH, Van Ommen GJ, Pearson PL. DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure. J Med Genet 1986;23:573-80.
5. Clemens PR, Fenwick RG, Chamberlain JS, Gibbs RA, de Andrade M, Chakraborty R, Caskey CT. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet 1991;49:951-60.
6. Prior TW, Bridgeman SJ. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J Mol Diagn 2005;7:317-26.
7. den Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB, Wapenaar MC, van Paassen HM, van Broeckhoven C, Pearson PL, van Ommen GJ. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 1989;45:835-47.
8. Janssen B, Hartmann C, Scholz V, Jauch A, Zschocke J. MLPA analysis for the defection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics 2005;6:29-35.
9. Yau SC, Bobrow M, Mathew CG, Abbs SJ. Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet 1996;33:550-8.
10. Flanigan KM, von Niederhausern A, Dunn DM, Alder J, Mendell JR, Weiss RB. Rapid direct sequence analysis of the dystrophin gene. Am J Hum Genet 2003;72:931-9.
11. Hu XY, Ray PN, Murphy EG, Thompson MW, Worton RG. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet 1990;46:682-95.
12. Dent KM, Dunn DM, von Niederhausern AC, Aoyagi AT, Kerr L, Bromberg MB, Hart KJ, Tuohy T, White S, den Dunnen JT, Weiss RB, Flanigan KM. Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. Am J Med Genet A 2005;134:295-8.
13. Yan J, Feng J, Buzin CH, Scaringe W, Liu Q, Mendell JR, den Dunnen J, Sommer SS. Three-tiered noninvasive diagnosis in 96% of patients with Duchenne muscular dystrophy (DMD). Hum Mutat 2004;23:203-4.
14. Lo IF, Lai KK, Tong TM, Lam ST. A different spectrum of DMD gene mutations in local Chinese patients with Duchenne/Becker muscular dystrophy. Chin Med J (Engl) 2006;119:1079-87.
15. Sinha S, Mishra S, Singh V, Mittal RD, Mittal B. High frequency of new mutations in North Indian Duchenne/Becker muscular dystrophy patients. Clin Genet 1996;50:327-31.
16. Alcantara MA, Villarreal MT, Del Castillo V, Gutierrez G, Saldana Y, Maulen I, Lee R, Macias M, Orozco L. High frequency of de novo deletions in Mexican Duchenne and Becker muscular dystrophy patients. Implications for genetic counseling. Clin Genet 1999;55:376-80.
17. Bakker E, Veenema H, Den Dunnen JT, van Broeckhoven C, Grootscholten PM, Bonten EJ, van Ommen GJ, Pearson PL. Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations. J Med Genet 1989;26:553-9.
18. Bridge PJ. The calculation of genetic risks: worked examples in DNA diagnostics, 2nd edn. Baltimore, London: The Johns Hopkins University Press, 1997.
19. White SJ, den Dunnen JT. Copy number variation in the genome; the human DMD gene as an example. Cytogenet Genome Res 2006;115:240-6.
20. Grosse SD, Khoury MJ. What is the clinical utility of genetic testing? Genet Med 2006;8:448-50.
21. Tuffery-Giraud S, Saquet C, Chambert S, Echenne B, Marie Cuisset J, Rivier F, Cossee M, Philippe C, Monnier N, Bieth E, Recan D, Antoinette Voelckel M, Perelman S, Lambert JC, Malcolm S, Claustres M. The role of muscle biopsy in analysis of the aystroph in gene in Duchenne muscular dystrophy: experience of a national referral centre. Neuromuscul Disord 2004;14:650-8.
22. Buzin CH, Feng J, Yan J, Scaringe W, Liu Q, den Dunnen J, Mendell JR, Sommer SS. Mutation rates in the dystrophin gene: a hotspot of mutation at a CpG dinucleotide. Hum Mutat 2005;25:177-88.
23. Aartsma-Rus A, Van Deutekom JC, Fokkema IF, Van Ommen GJ, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame njle. Muscle Nerve 2006;34:135-44.
24. Shomrat R, Gluck E, Legum C, Shiloh Y. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients. Am J Med Genet 1994;49:369-73.
25. Onengut S, Kavaslar GN, Battaloglu E, Serdaroglu P, Deymeer F, Ozdemir C, Calafell F, Tolun A. Deletion pattern in the dystrophin gene in Turks and a comparison with Europeans and Indians. Ann Hum Genet 2000;64:33-40.
26. Singh V, Sinha S, Mishra S, Chaturvedi LS, Pradhan S, Mittal RD, Mittal B. Proportion and pattern of dystrophin gene deletions in north Indian Duchenne and Becker muscular dystrophy patients. Hum Genet 1997;99:206-8.
27. Galvagni F, Saad FA, Danieli GA, Miorin M, Vitiello L, Mostacciuolo ML, Angelini C. A study on duplications of the dystrophin gene: evidence of a geographical difference in the distribution of breakpoints by intron. Hum Genet 1994;94:83-7.
28. Mukherjee M, Chaturvedi LS, Srivastava S, Mittal RD, Mittal B. De novo mutations in sporadic deletional Duchenne muscular dystrophy (DMD) cases. Exp Mol Med 2003;35:113-17.
29. Grimm T, Meng G, Liechti-Gallati S, Bettecken T, Muller CR, Muller B. On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis. J Med Genet 1994;31:183-6.